Bowhead Specialty (NYSE:BOW - Get Free Report) had its price objective boosted by equities researchers at Keefe, Bruyette & Woods from $30.00 to $33.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a "market perform" rating on the stock. Keefe, Bruyette & Woods' price target would indicate a potential upside of 9.78% from the company's previous close.
BOW has been the subject of a number of other research reports. JMP Securities increased their price objective on Bowhead Specialty from $31.00 to $32.00 and gave the company a "market outperform" rating in a research note on Tuesday, October 15th. Royal Bank of Canada reiterated an "outperform" rating and set a $32.00 price target on shares of Bowhead Specialty in a report on Tuesday. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $30.00.
View Our Latest Report on Bowhead Specialty
Bowhead Specialty Stock Up 0.3 %
Bowhead Specialty stock traded up $0.09 during mid-day trading on Tuesday, hitting $30.06. The company's stock had a trading volume of 306,723 shares, compared to its average volume of 180,053. The business has a 50 day moving average of $29.54. Bowhead Specialty has a 12 month low of $22.14 and a 12 month high of $32.55.
Bowhead Specialty (NYSE:BOW - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.27 by $0.01. The company had revenue of $98.90 million during the quarter, compared to analysts' expectations of $94.28 million. The company's quarterly revenue was up 51.0% compared to the same quarter last year. As a group, equities analysts expect that Bowhead Specialty will post 1.3 earnings per share for the current fiscal year.
Insider Transactions at Bowhead Specialty
In related news, Director Family Mutual Insuran American sold 1,362,285 shares of Bowhead Specialty stock in a transaction on Friday, October 25th. The shares were sold at an average price of $27.70, for a total value of $37,735,294.50. Following the sale, the director now owns 4,700,761 shares in the company, valued at $130,211,079.70. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Institutional Trading of Bowhead Specialty
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Peregrine Capital Management LLC bought a new position in Bowhead Specialty in the second quarter worth $3,073,000. Lighthouse Investment Partners LLC purchased a new position in Bowhead Specialty during the 2nd quarter valued at about $2,653,000. Sei Investments Co. bought a new stake in Bowhead Specialty during the second quarter worth about $2,021,000. The Manufacturers Life Insurance Company bought a new stake in Bowhead Specialty during the second quarter worth about $1,458,000. Finally, Emerald Mutual Fund Advisers Trust purchased a new stake in Bowhead Specialty in the second quarter worth about $4,901,000.
Bowhead Specialty Company Profile
(
Get Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Further Reading
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.